(S)-14k is pyridone ERK1/2 inhibitor optimized to be a potent, selective and orally bioavailable agent that inhibited tumor growth in mouse xenograft models. On the basis of its in vivo efficacy and preliminary safety profiles in several sepcies, (S)-14k was selected for further preclinical evaluation. ErK2 enzyme Ki = 0.3+0.02 nM, CDK2 enzyme Ki = 21+8 nM, Phospho-p90RSK = 17+4 nM.
Systematic Name: (S)-1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((tetrahydro-2H-pyran-4-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one
Chemical Formula: C22H22ClFN4O3
Molecular Weight: 444.89
Reference: Ren, Li, et al. "Discovery of Highly Potent, Selective and Efficacious Small Molecule Inhibitors of ERK1/2." Journal of Medicinal Chemistry (2015).
Interested in this reagent? E-mail us at firstname.lastname@example.org and let us know.
Tags: CDK2, Cancer, ERK, Tumor, RGNCY-0027, (S)-14, ERK1, ERK2